Canadian Sec CAD

Aion Therapeutic Inc. (AION.CN)

Compare
0.0100 0.0000 (0.00%)
At close: January 3 at 3:35:07 PM EST
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Total Revenue
1,149.9640
367.4790
--
--
--
Cost of Revenue
647.7560
204.3620
--
--
--
Gross Profit
502.2080
163.1170
--
--
--
Operating Expense
2,083.6680
1,354.0660
975.6990
2,818.9130
2,780.0230
Operating Income
-1,581.4600
-1,190.9490
-975.6990
-2,818.9130
-2,780.0230
Net Non Operating Interest Income Expense
-211.9910
-156.4000
-149.8420
-75.7160
-186.0650
Other Income Expense
-4,937.4300
-4,939.8470
868.8830
-923.7610
-5,299.0600
Pretax Income
-6,730.8810
-6,287.1960
-256.6580
-3,818.3900
-8,265.1480
Net Income Common Stockholders
-6,730.8810
-6,287.1960
-256.6580
-3,818.3900
-8,265.1480
Diluted NI Available to Com Stockholders
-6,730.8810
-6,287.1960
-256.6580
-3,818.3900
-8,265.1480
Basic EPS
-0.02
-0.02
-0.00
-0.03
-0.09
Diluted EPS
-0.02
-0.02
-0.00
-0.03
-0.09
Basic Average Shares
414,883.4210
265,071.8720
146,395.1590
139,890.3010
93,897.0860
Diluted Average Shares
414,883.4210
265,071.8720
146,395.1590
139,890.3010
93,897.0860
Rent Expense Supplemental
21.6920
11.6030
5.8160
114.9580
99.5880
Total Expenses
2,731.4240
1,558.4280
975.6990
2,818.9130
2,780.0230
Net Income from Continuing & Discontinued Operation
-6,730.8810
-6,287.1960
-256.6580
-3,818.3900
-8,265.1480
Normalized Income
-1,793.4510
-1,347.3490
-1,125.5410
-2,894.6290
-2,966.0880
Interest Income
6.2920
14.9920
--
--
--
Interest Expense
218.2830
171.3920
149.8420
75.7160
186.0650
Net Interest Income
-211.9910
-156.4000
-149.8420
-75.7160
-186.0650
EBIT
-6,512.5980
-6,115.8040
-106.8160
-3,742.6740
-8,079.0830
EBITDA
-6,413.2230
-6,073.6980
-89.5150
-3,677.3810
-7,950.9530
Reconciled Cost of Revenue
647.7560
204.3620
--
--
--
Reconciled Depreciation
99.3750
42.1060
17.3010
65.2930
128.1300
Net Income from Continuing Operation Net Minority Interest
-6,730.8810
-6,287.1960
-256.6580
-3,818.3900
-8,265.1480
Total Unusual Items Excluding Goodwill
-4,937.4300
-4,939.8470
868.8830
-923.7610
-5,299.0600
Total Unusual Items
-4,937.4300
-4,939.8470
868.8830
-923.7610
-5,299.0600
Normalized EBITDA
-1,475.7930
-1,133.8510
-958.3980
-2,753.6200
-2,651.8930
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AYUR.CN Ayurcann Holdings Corp.
0.0250
0.00%
 
RDDTF Radient Technologies Inc.
0.0000
0.00%
 
MYCO.CN Mydecine Innovations Group Inc.
0.0050
-50.00%
 
AUSAF Australis Capital Inc.
0.0001
0.00%
 
FFNTF 4Front Ventures Corp.
0.0130
+4.00%
 
RVV.CN Revive Therapeutics Ltd.
0.0050
0.00%
 
VREOF Vireo Growth Inc.
0.5400
-1.82%
 
LOVE.V Cannara Biotech Inc.
0.8200
+6.49%
 
ASRT Assertio Holdings, Inc.
0.8307
-3.62%
 
WEED.TO Canopy Growth Corporation
3.8500
-6.78%